Quercetin Alginate Nanogels Loaded with BDNF for Depression (2023 Study)

TLDR: Quercetin-based alginate nanogels loaded with brain-derived neurotrophic factor (BDNF) can effectively cross the blood-brain barrier via intranasal delivery, providing a promising treatment for depressive disorders. Highlights: Nanogels: Quercetin nanogels protect BDNF from oxidative damage, exhibit rapid brain distribution, and significantly enhance bioavailability compared to oral administration. Efficacy: BDNF-Quercetin nanogels delivered via intranasal route show …

Read more

Esketamine Nasal Spray Rapidly Treats Depression & Suicidal Ideation (2023 Study)

TLDR: Esketamine nasal spray, combined with standard antidepressant therapy, significantly improves remission rates and reduces time to remission in adults with major depressive disorder (MDD) and acute suicidality compared to standard care alone. Highlights: Remission Rates: Patients treated with esketamine plus standard of care had higher remission rates than those treated with placebo plus standard …

Read more

Rethinking Long-Term Antidepressant Use: Weighing Benefits vs. Risks

Antidepressant use has risen steadily for 30 years. Over 10% of adults in England now take them long-term, but evidence suggests up to half lack clear medical justification to continue. Patients and doctors are reluctant to stop treatment due to fears of relapse and withdrawal effects. Research indicates more proactive treatment review, slower drug tapering …

Read more

Most Effective Smoking Cessation Aids: Varenicline, Cytisine, E-Cigs (Evidence Review)

New research provides clarity on the most effective cessation aids available. Varenicline, cytisine, and e-cigarettes help the greatest proportion of people quit long-term. Slowly tapering nicotine dose before ending treatment may also boost success rates. Bupropion slightly raises the risk of serious side effects. Key Facts: Varenicline, cytisine, and e-cigarettes have the highest quit rates, …

Read more

Antidepressants for Insomnia Treatment in Adults: Are They Effective? (Cochrane Review Findings)

Insomnia is a common sleep disorder affecting up to 15% of adults. While sedative medications are often prescribed, their long-term use can lead to dependence. As an alternative, antidepressants are widely used in clinical practice despite limited evidence supporting their efficacy and safety for insomnia. Key Facts: Insomnia affects up to 15% of adults, causing …

Read more

Antidepressants & Cardiovascular Effects: SNRIs, Atypicals, Others

Depression is highly prevalent in older adults and those with cardiovascular disease. Selective serotonin reuptake inhibitors (SSRIs) are generally safe first-line treatments, but many wonder if they’re safe for those with cardiovascular disease. Key Facts: There is insufficient evidence to confirm the safety of most newer antidepressants for older and cardiovascular patients. SNRIs like venlafaxine …

Read more

How do Antidepressants Work in the Brain? Delayed Onset vs. Rapid-Acting & Neuroplasticity

Current antidepressants can take weeks to improve symptoms of depression. New research explores reasons for this delay and provides clues to develop more rapid-acting drugs. Key Facts: Most antidepressants increase brain serotonin and norepinephrine, but their mood benefits are delayed for weeks. Researchers are investigating other mechanisms that could explain this lag. Two leading theories …

Read more

Navigating Mild Depression: Early Treatment, Psychotherapy, Antidepressants

Minor or subthreshold depression causes significant suffering and impairment, despite falling short of a major depression diagnosis. Effective early treatment is crucial to alleviate symptoms, improve functioning, and prevent progression to major depression. Both psychotherapy and antidepressants show efficacy, with antidepressants possibly having a slight advantage. In a shared decision-making model, patient preferences and values …

Read more

Dapoxetine (SSRI) May Treat Zika Virus via Antiviral Effects

Zika virus (ZIKV) is a mosquito-borne flavivirus that has emerged as a significant global health threat, but there are currently no approved antiviral drugs for treating ZIKV infection. A new study identifies the SSRI drug dapoxetine as a promising antiviral candidate against ZIKV by targeting and inhibiting its RNA-dependent RNA polymerase. Key Facts: Dapoxetine was …

Read more

Complex Effects of Antidepressants on Sleep & Depression: What You Should Know

Depression often comes with significant sleep disturbances that can persist even after other symptoms improve. Choosing an antidepressant that alleviates sleep problems may improve outcomes. Key Facts: Sleep complaints like insomnia occur in 60-90% of depression patients. Poor sleep is associated with higher suicide risk. Sedative antidepressants like mirtazapine quickly improve sleep, while SSRIs/SNRIs may …

Read more